Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-11-30 | 2021-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | |||||||||||||||||
net income | 249,000,000 | 228,000,000 | 211,000,000 | -729,000,000 | 178,000,000 | 155,000,000 | 134,000,000 | 278,000,000 | 249,000,000 | 237,000,000 | 254,000,000 | 668,000,000 | 336,000,000 | 264,000,000 | 178,000,000 | 5,000,000 | 5,000,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||
depreciation and amortization | 314,000,000 | 335,000,000 | 352,000,000 | 392,000,000 | 343,000,000 | 415,000,000 | 415,000,000 | ||||||||||
share-based compensation | 53,000,000 | 52,000,000 | 42,000,000 | 50,000,000 | 41,000,000 | 33,000,000 | 51,000,000 | 53,000,000 | |||||||||
gain on acquisition of joint venture interest | 0 | 0 | -31,000,000 | ||||||||||||||
finance income | -41,000,000 | -39,000,000 | -39,000,000 | -49,000,000 | -52,000,000 | ||||||||||||
finance expense | 23,000,000 | 22,000,000 | 25,000,000 | 34,000,000 | 37,000,000 | 27,000,000 | 27,000,000 | ||||||||||
deferred income taxes | -6,000,000 | -20,000,000 | -64,000,000 | 6,000,000 | 37,000,000 | 6,000,000 | 23,000,000 | 8,000,000 | -4,000,000 | 24,000,000 | 22,000,000 | 30,000,000 | 11,000,000 | 22,000,000 | 19,000,000 | 20,000,000 | 20,000,000 |
gain on disposal of property, plant and equipment | -37,000,000 | -39,000,000 | -32,000,000 | -5,000,000 | |||||||||||||
other operating activities | -6,000,000 | 19,000,000 | -12,000,000 | 1,000,000 | |||||||||||||
change in assets and liabilities, net of acquisitions: | |||||||||||||||||
receivables, prepayments and other assets | 168,000,000 | ||||||||||||||||
inventories | 81,000,000 | 88,000,000 | -177,000,000 | 179,000,000 | -17,000,000 | 22,000,000 | -5,000,000 | -40,000,000 | -80,000,000 | -77,000,000 | -64,000,000 | ||||||
trade and other payables | -233,000,000 | -128,000,000 | 33,000,000 | -17,000,000 | -15,000,000 | -175,000,000 | -28,000,000 | 26,000,000 | 237,000,000 | ||||||||
net change in working capital | 16,000,000 | -97,000,000 | -174,000,000 | ||||||||||||||
interest received | 45,000,000 | 34,000,000 | 32,000,000 | 41,000,000 | 44,000,000 | ||||||||||||
interest paid | -8,000,000 | -20,000,000 | -8,000,000 | -40,000,000 | -17,000,000 | ||||||||||||
income taxes paid | -7,000,000 | -5,000,000 | -1,000,000 | -14,000,000 | |||||||||||||
net cash from operating activities | 595,000,000 | 431,000,000 | 331,000,000 | 457,000,000 | 375,000,000 | 402,000,000 | 488,000,000 | 684,000,000 | 416,000,000 | 546,000,000 | 479,000,000 | 491,000,000 | 679,000,000 | 609,000,000 | 845,000,000 | 1,109,000,000 | 1,109,000,000 |
capital expenditures | -189,000,000 | -159,000,000 | -166,000,000 | 0 | -109,000,000 | 0 | -227,000,000 | 0 | -304,000,000 | 0 | -853,000,000 | 0 | -601,000,000 | -796,000,000 | -612,000,000 | -392,000,000 | -392,000,000 |
free cash flows | 406,000,000 | 272,000,000 | 165,000,000 | 457,000,000 | 266,000,000 | 402,000,000 | 261,000,000 | 684,000,000 | 112,000,000 | 546,000,000 | -374,000,000 | 491,000,000 | 78,000,000 | -187,000,000 | 233,000,000 | 717,000,000 | 717,000,000 |
investing activities | |||||||||||||||||
acquisitions, net of cash acquired | 0 | ||||||||||||||||
purchases of property, plant and equipment and intangible assets | -189,000,000 | -159,000,000 | -166,000,000 | ||||||||||||||
purchases of equity securities | 3,000,000 | ||||||||||||||||
purchases of marketable securities | -460,000,000 | -388,000,000 | -397,000,000 | -349,000,000 | -480,000,000 | ||||||||||||
proceeds from sale of marketable securities | 152,000,000 | 25,000,000 | 50,000,000 | 34,000,000 | -545,000,000 | 198,000,000 | |||||||||||
proceeds from maturities of marketable securities | 292,000,000 | 340,000,000 | 286,000,000 | 329,000,000 | |||||||||||||
proceeds from the sale of property plant and equipment and other | 85,000,000 | 43,000,000 | 35,000,000 | ||||||||||||||
net cash from investing activities | -329,000,000 | -207,000,000 | -211,000,000 | -92,000,000 | -263,000,000 | -170,000,000 | -600,000,000 | -95,000,000 | -313,000,000 | -888,000,000 | -586,000,000 | -1,051,000,000 | -764,000,000 | -1,604,000,000 | -639,000,000 | -362,000,000 | -362,000,000 |
financing activities | |||||||||||||||||
net proceeds from borrowings | 5,000,000 | 2,000,000 | 0 | 2,000,000 | 359,000,000 | 169,000,000 | 229,000,000 | 214,000,000 | |||||||||
repayments of debt and lease obligations | -25,000,000 | -50,000,000 | -733,000,000 | -454,000,000 | -39,000,000 | ||||||||||||
proceeds from issuance of equity instruments, net of taxes paid | |||||||||||||||||
purchase of treasury stock | 0 | 0 | |||||||||||||||
net cash from financing activities | -40,000,000 | -35,000,000 | -717,000,000 | -452,000,000 | -12,000,000 | -294,000,000 | -27,000,000 | -87,000,000 | -54,000,000 | 360,000,000 | 157,000,000 | 207,000,000 | 118,000,000 | -525,000,000 | -525,000,000 | ||
effect of exchange rate changes on cash and cash equivalents | 0 | 5,000,000 | 1,000,000 | 5,000,000 | 11,000,000 | -5,000,000 | -2,000,000 | 1,000,000 | |||||||||
net decrease in cash and cash equivalents | 226,000,000 | 194,000,000 | -596,000,000 | 102,000,000 | 48,000,000 | ||||||||||||
cash and cash equivalents at the beginning of the period | 0 | 0 | 2,192,000,000 | 0 | 0 | 2,387,000,000 | 0 | 0 | 2,352,000,000 | 0 | 0 | 2,939,000,000 | 805,000,000 | 805,000,000 | |||
cash and cash equivalents at the end of the period | 226,000,000 | 194,000,000 | 1,596,000,000 | 102,000,000 | -63,000,000 | 2,247,000,000 | 48,000,000 | -424,000,000 | 2,256,000,000 | 67,000,000 | -790,000,000 | 3,264,000,000 | 1,019,000,000 | 1,019,000,000 | |||
acquisition of joint venture interest, net of cash acquired | 0 | -19,000,000 | |||||||||||||||
proceeds from issuance of equity instruments | 1,000,000 | 16,000,000 | |||||||||||||||
change in assets and liabilities, net of acquisitions: - sum | -144,000,000 | ||||||||||||||||
impairment charges | |||||||||||||||||
share-based payments | |||||||||||||||||
amortization of deferred income from government grants | -9,000,000 | -6,000,000 | -6,000,000 | -7,000,000 | -7,000,000 | -8,000,000 | |||||||||||
loss on disposal of property, plant and equipment and other | 20,000,000 | -19,000,000 | |||||||||||||||
gain on the sale of a business | |||||||||||||||||
change in assets and liabilities: | |||||||||||||||||
proceeds from government grants | |||||||||||||||||
advances and proceeds from sale of property, plant and equipment and intangible assets | 2,000,000 | 8,000,000 | 2,000,000 | 15,000,000 | 15,000,000 | 9,000,000 | |||||||||||
proceeds from sale of a business | |||||||||||||||||
other investing activities | -37,000,000 | 30,000,000 | 379,000,000 | -373,000,000 | -1,000,000 | 2,000,000 | -270,000,000 | 267,000,000 | -4,000,000 | -18,000,000 | -17,000,000 | -5,000,000 | 30,000,000 | 30,000,000 | |||
other financing activities | 3,000,000 | 11,000,000 | 4,000,000 | 4,000,000 | |||||||||||||
net increase in cash and cash equivalents | -189,000,000 | 325,000,000 | |||||||||||||||
cash and cash equivalents at the beginning of the year | |||||||||||||||||
cash and cash equivalents at the end of the year | |||||||||||||||||
depreciation | 363,000,000 | 333,000,000 | 358,000,000 | 363,000,000 | 356,000,000 | ||||||||||||
amortization of intangible assets | 33,000,000 | 33,000,000 | 37,000,000 | 48,000,000 | 52,000,000 | ||||||||||||
gain on disposal of property, plant and equipment and other | -35,000,000 | -22,000,000 | -57,000,000 | ||||||||||||||
receivables, prepayments, other assets and other non-current assets | -141,000,000 | ||||||||||||||||
current and non-current trade and other payables | -105,000,000 | ||||||||||||||||
purchases of property, plant and equipment | -109,000,000 | -304,000,000 | -601,000,000 | -796,000,000 | -612,000,000 | ||||||||||||
purchase of intangible assets | -53,000,000 | -20,000,000 | |||||||||||||||
proceeds from issuance of equity instruments and other | 23,000,000 | 1,000,000 | 9,000,000 | 37,000,000 | 62,000,000 | ||||||||||||
cash flows from operating activities | |||||||||||||||||
income taxes (paid) refunded | |||||||||||||||||
cash flows from investing activities | |||||||||||||||||
cash flows from financing activities | |||||||||||||||||
cash flows from operating activities: | |||||||||||||||||
finance expense, net and other | 6,000,000 | 7,000,000 | |||||||||||||||
other non-cash operating activities | 30,000,000 | 27,000,000 | 2,000,000 | 2,000,000 | |||||||||||||
cash flows from investing activities: | |||||||||||||||||
purchases of property, plant, equipment, and intangible assets | -227,000,000 | -853,000,000 | -392,000,000 | -392,000,000 | |||||||||||||
cash flows from financing activities: | |||||||||||||||||
proceeds (repayment) of debt | -50,000,000 | -30,000,000 | |||||||||||||||
effect of exchange rate changes | 1,000,000 | -8,000,000 | -8,000,000 | ||||||||||||||
net change in cash and cash equivalents | -140,000,000 | -96,000,000 | 214,000,000 | 214,000,000 | |||||||||||||
interest and income taxes paid | -14,000,000 | -6,000,000 | -30,000,000 | -18,000,000 | |||||||||||||
purchase of marketable securities | |||||||||||||||||
repayments of shareholder loan | -442,000,000 | -442,000,000 | |||||||||||||||
repayments of debt and finance lease obligations | -87,000,000 | -57,000,000 | -104,000,000 | -74,000,000 | -105,000,000 | -107,000,000 | |||||||||||
increase in restricted cash | |||||||||||||||||
interest, income taxes paid and finance income | |||||||||||||||||
receivables, prepayments, other assets and other noncurrent assets | -198,000,000 | 71,000,000 | -50,000,000 | 16,000,000 | |||||||||||||
proceeds from the sale of efk business | 0 | ||||||||||||||||
purchases of investment in marketable securities | -216,000,000 | ||||||||||||||||
proceeds from the sale of investment in marketable securities | 217,000,000 | ||||||||||||||||
noncash investing and financing activities: | |||||||||||||||||
amounts payable for property, plant and equipment | -118,000,000 | -131,000,000 | 500,000,000 | 13,000,000 | 519,000,000 | ||||||||||||
property, plant and equipment acquired through lease | 8,000,000 | 5,000,000 | 0 | 1,000,000 | 60,000,000 | ||||||||||||
amounts payable for intangible assets | -11,000,000 | -10,000,000 | -7,000,000 | -8,000,000 | 114,000,000 | ||||||||||||
net cash provided by financing activities | 10,000,000 | ||||||||||||||||
finance expense, net and other has been adjusted to include interest and taxes paid that were previously included in "other non-cash operating activities." prior period amounts have been adjusted accordingly. | |||||||||||||||||
finance expenses | 53,000,000 | 11,000,000 | 19,000,000 | 28,000,000 | |||||||||||||
purchase of investment in marketable securities | -256,000,000 | -256,000,000 | |||||||||||||||
proceeds from sale of fabrication facilities and asic business | |||||||||||||||||
repayments of borrowings from shareholder | |||||||||||||||||
purchases of intangible assets | -12,000,000 | -16,000,000 | -31,000,000 | ||||||||||||||
net loss | |||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||
gain on sale of fabrication facilities | |||||||||||||||||
income tax payable | |||||||||||||||||
income tax paid | |||||||||||||||||
loans issued to related parties | |||||||||||||||||
proceeds from settlement of loans issued to joint ventures and associates | |||||||||||||||||
net cash from (used in) investing activities | |||||||||||||||||
decrease in restricted cash | |||||||||||||||||
change in net working capital | 640,000,000 | 640,000,000 | |||||||||||||||
repayment of debt | -87,000,000 | -87,000,000 | |||||||||||||||
• |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
